EXAGEN INC.
10-K
March 10, 2026
Key Highlights
- Flagship AVISE CTD Test for autoimmune diseases drives commercialization efforts...
- Successfully raised significant capital through a public offering, At-The-Market...
- Strengthening capital structure and managing debt profile to fund ongoing operat...
Read Analysis
🤖 AI Generated